Figure 1:

Figure 2:

Survival of entomopathogenic nematodes produced in vivo and in vitro and formulated in either Barricade® gel (B) or Potassium Polyacrylate Hydrogel (PPH) (LSD (P < 0001) = 20_64)_
| Strain | Formulation | Day 1 | 2 weeks | 4 weeks | 6 weeks | 8 weeks |
|---|---|---|---|---|---|---|
| SGI 245 | In vivo B | 100 a | 59 a | 56 a | 37 b | 13 a |
| In vitro B | 100 a | 64 a | 65 a | 67 a | 8 a | |
| In vivo PPH | 100 a | 59 a | 55 a | 37 b | 13 a | |
| In vitro PPH | 100 a | 61 a | 63 a | 68 a | 10 a | |
| In vivo control | 100 a | 0 b | * | * | * | |
| In vitro control | 100 a | 0 b | * | * | * | |
| ROOI 352 | In vivo B | 100 a | 76 a | 60 a | 47 b | 4 a |
| In vitro B | 100 a | 62 b | 57 a | 66 a | * | |
| In vivo PPH | 100 a | 76 a | 60 a | 47 b | 4 a | |
| In vitro PPH | 100 a | 62 b | 63 a | 66 c | 2 a | |
| In vivo control | 100 a | 0 c | * | * | * | |
| In vitro control | 100 a | 0 c | * | * | * | |
| SGI 35 | In vivo B | 100 a | 68 a | 53 a | 47 b | * |
| In vitro B | 100 a | 58 b | 63 a | 68 a | * | |
| In vivo PPH | 100 a | 68 a | 53 a | 47 b | * | |
| In vitro PPH | 100 a | 60 b | 69 a | 69 a | 1 | |
| In vivo control | 100 a | 0 c | * | * | * | |
| In vitro control | 100 a | 0 c | * | * | * |
Table showing infectivity of entomopathogenic nematodes produced in vivo and in vitro against Tenebrio molitor and formulated in either Barricade® gel (B) or Potassium Polyacrylate Hydrogel (PPH) (LSD (P = 0,05) = 6,1742)_
| Strain | Formulation | Day 1 | 2 weeks | 4 weeks | 6 weeks | 8 weeks |
|---|---|---|---|---|---|---|
| SGI 245 | In vivo B | 100 a | 90 a | 93 a | 70 a | 57 a |
| In vitro B | 100 a | 83 a | 77 b | 70 a | 50 a | |
| In vivo PPH | 100 a | 90 a | 90 a | 70 a | 53 a | |
| In vitro PPH | 100 a | 90 a | 80 b | 73 a | 53 a | |
| In vivo control | 100 a | 0 b | * | * | * | |
| In vitro control | 100 a | 0 b | * | * | * | |
| ROOI 352 | In vivo B | 100 a | 97 a | 100 a | 83 a | 90 a |
| In vitro B | 100 a | 97 a | 73 c | 67 b | * | |
| In vivo PPH | 100 a | 100 a | 100 a | 90 a | 93 a | |
| In vitro PPH | 100 a | 100 a | 80 b | 67 b | 93 a | |
| In vivo control | 100 a | 0 b | * | * | * | |
| In vitro control | 100 a | 0 b | * | * | * | |
| SGI 35 | In vivo B | 100 a | 93 a | 90 a | 80 a | * |
| In vitro B | 100 a | 80 b | 77 a | 57 b | * | |
| In vivo PPH | 100 a | 93 a | 90 a | 80 a | * | |
| In vitro PPH | 100 a | 80 b | 80 a | 60 b | 93 | |
| In vivo control | 100 a | 0 c | * | * | * | |
| In vitro control | 100 a | 0 c | * | * | * |